MedTrace Logo

Evaluation of the Mechanisms of Sarcopenia in Chronic Inflammatory Disease: Protocol for a Prospective Cohort Study

NCT04734496 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2021-02-02

No results posted yet for this study

Summary

Prospective, observational study to assess sarcopenia across three chronic inflammatory diseases: chronic liver disease, Inflammatory Bowel Disease, Rheumatoid Arthritis both before and after therapeutic intervention (standard of care treatment i.e. nutrition/exercise; biologic for IBD etc).

Conditions

Interventions

OTHER

National Healthcare System Standard of care for each disease type (National Institute for Health and Care Excellence guidelines)

National Healthcare System Standard of care for each disease type (National Institute for Health and Care Excellence guidelines)

Sponsors & Collaborators

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • University of Birmingham

    lead OTHER

Principal Investigators

  • Janet Lord, PhD · University of Birmingham

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-04-01
Completion
2021-09-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04734496 on ClinicalTrials.gov